Basics Beam Therapeutics Inc. IPO Date: February 6, 2020 Sector: Healthcare Industry: Biotech Market Cap: $1.99B Activated in VL: True Average Daily Range Avg Daily Range: $1.62 | 3.52% Avg Daily Range (30 D): $0.81 | 4.63% Avg Daily Range (90 D): $0.92 | 3.96% Institutional Daily Volume Avg Daily Volume: .87M Avg Daily Volume (30 D): 2.42M Avg Daily Volume (90 D): 1.7M Trade Size Avg Trade Size (Sh.): 58 Avg Trade Size (Sh.) (30 D): 77 Avg Trade Size (Sh.) (90 D): 68 Institutional Trades Total Inst.Trades: 2,898 Avg Inst. Trade: $3.16M Avg Inst. Trade (30 D): $2.97M Avg Inst. Trade (90 D): $2.86M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $4.89M Avg Closing Trade (30 D): $4.49M Avg Closing Trade (90 D): $5.14M Avg Closing Volume: 129.02K         News May 6, 2025 @ 9:05 PM Why Beam Therapeutics Stock Tanked on Tuesday Source: Eric Volkman Mar 10, 2025 @ 10:01 AM Beam Therapeutics Announces Pricing of Underwritte... Source: N/A Feb 24, 2025 @ 12:00 PM Beam Therapeutics to Participate in Upcoming March... Source: N/A Jan 30, 2025 @ 12:00 PM Beam Therapeutics to Participate in Guggenheim SMI... Source: N/A Dec 19, 2024 @ 6:00 PM Comprehensive Market Analysis of Latest Published ... Source: Delveinsight Financials   TTM Q1 2025 Q4 2024 Basic EPS $-4.61 $-1.24 $-1.09 Diluted EPS $-4.61 $-1.24 $-1.09 Revenue $ 63.58M $ 7.47M $ 30.07M Gross Profit $ $ $ Net Income / Loss $ -387.34M $ -109.27M $ -90.35M Operating Income / Loss $ -430.72M $ -119.29M $ -100.04M Cost of Revenue $ $ $ Net Cash Flow $ 240.22M $ 244.41M $ 53.36M PE Ratio